Cristopher McReynolds has been named vice president of business development at Alverix.
He previously was CEO of Satoris. Before that, McReynolds was VP of business development for Affymetrix's molecular diagnostics business unit. Prior to working at Affy, McReynolds held the same role at Cepheid.
Illumina's stockholders have re-elected Daniel Bradbury and Roy Whitfield to serve on the firm's board of directors for three years and Gerald Möller to serve on the board for two years.
Bradbury has been a director of Illumina since 2004, while Whitfield has been a member of the board since 2007. Möller was named a director last year.
Rosetta Genomics said last week that Moshe Many has resigned from the company's board of directors. Moshe is leaving the board "due to time constraints from other professional commitments," the company said.